2-(2-Fluorophenyl)-1H-imidazole-5-carbaldehyde, 97%, 1g

methyl (3-methyl-2-oxo-1-piperazinyl)acetate hydrobromide, 95.0%, 1g

GC-Kapillarsäule ROTI®Cap-1701, L 60 m, Ø-Innen 0,32 mm, Filmd. 0,35 µm, 1 Stück

2-(3-Formyl-2-methyl-indol-1-yl)-acetamide, 95.0%, 1g

2-(3,6-Bis(dimethylamino)xanthylium-9-yl)-5-carboxybenzoate, 95.0%, 10mg

2,4-Dichloro-7-methylthieno[3,2-d]pyrimidine, 95.0%, 10g

2,4,5-Trifluorobenzamide, 97.0%, 5g

1,8-Naphthyridin-2(1H)-one, 95.0%, 1g

CYCLOPROPYL(4-HYDROXYPHENYL)METHANONE, 95.0%, 1g

6-(Azetidin-2-yl)-2-methylpyrimidin-4-amine 2,2,2-trifluoroacetate, 1g

3-Ethyloxetan-3-amine hydrochloride, 95.0%, 250mg

L-Rhamnose monohydrate, 98.0%, 250g

2-(Piperidin-3-yl)pyridine, 95.0%, 100mg